DIMENSIONAL FUND ADVISORS LP
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 354204
AUSTIN, TX
Position in MDGL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,770,263
+$310,299 QoQ
Shares Held
8,884
+4.3% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#120
of 411 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. MDGL ranks #107 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in MDGL
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,770,263 | 8,884 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $4,459,964 | 8,520 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $11,251,389 | 19,321 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,659,769 | 5,799 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,171,216 | 3,870 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,273,248 | 3,844 | Shares | Sole | 2025-05-13 | |
| 2023-06-30 | $3,775,695 | 16,345 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,949,080 | 16,301 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $3,796,179 | 13,079 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,989,212 | 45,995 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $12,118,062 | 169,294 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $21,213,249 | 216,197 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $17,143,918 | 202,312 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $13,916,333 | 174,412 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $16,479,044 | 169,172 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $20,178,611 | 172,511 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $20,992,231 | 188,830 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $23,717,979 | 199,764 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $22,539,015 | 199,020 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,196,983 | 197,678 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||